Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 May 26;22(11):5640.
doi: 10.3390/ijms22115640.

Current Advances on the Important Roles of Enhancer RNAs in Molecular Pathways of Cancer

Affiliations
Review

Current Advances on the Important Roles of Enhancer RNAs in Molecular Pathways of Cancer

Rui Wang et al. Int J Mol Sci. .

Abstract

Enhancers are critical genomic elements that can cooperate with promoters to regulate gene transcription in both normal and cancer cells. Recent studies reveal that enhancer regions are transcribed to produce a class of noncoding RNAs referred to as enhancer RNAs (eRNAs). Emerging evidence shows that eRNAs play important roles in enhancer activation and enhancer-driven gene regulation, and the expression of eRNAs may be a critical factor in tumorigenesis. The important roles of eRNAs in cancer signaling pathways are also gradually unveiled, providing a new insight into cancer therapy. Here, we review the roles of eRNAs in regulating cancer signaling pathways and discuss the potential of eRNA-targeted therapy for human cancers.

Keywords: cancer signaling pathway; cancer therapy; eRNA.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
eRNAs regulate gene expression by promoting enhancer–promoter looping.
Figure 2
Figure 2
Pathways regulated by eRNA and pathways regulating eRNA expression. (A) eRNA CCAT1 activates PI3K/AKT and MEK/ERK1/2 signaling pathways. (B) Expression of LPS-induced eRNAs is regulated by divergent signaling pathways.
Figure 3
Figure 3
Pipeline for eRNA detection.

Similar articles

Cited by

References

    1. Kim T.-K., Hemberg M., Gray J.M., Costa A.M., Bear D.M., Wu J., Harmin D.A., Laptewicz M., Barbara-Haley K., Kuersten S., et al. Widespread transcription at neuronal activity-regulated enhancers. Nature. 2010;465:182–187. - PMC - PubMed
    1. Andersson R., The FANTOM Consortium. Gebhard C., Miguel-Escalada I., Hoof I., Bornholdt J., Boyd M., Chen Y., Zhao X., Schmidl C., et al. An atlas of active enhancers across human cell types and tissues. Nature. 2014;507:455–461. doi: 10.1038/nature12787. - DOI - PMC - PubMed
    1. Kaikkonen M.U., Spann N.J., Heinz S., Romanoski C.E., Allison K.A., Stender J.D., Chun H.B., Tough D.F., Prinjha R.K., Benner C., et al. Remodeling of the Enhancer Landscape during Macrophage Activation Is Coupled to Enhancer Transcription. Mol. Cell. 2013;51:310–325. doi: 10.1016/j.molcel.2013.07.010. - DOI - PMC - PubMed
    1. Djebali S., Davis C.A., Merkel A., Dobin A., Lassmann T., Mortazavi A., Tanzer A., Lagarde J., Lin W., Schlesinger F., et al. Landscape of transcription in human cells. Nature. 2012;489:101–108. doi: 10.1038/nature11233. - DOI - PMC - PubMed
    1. Wu H., Nord A.S., Akiyama J.A., Shoukry M., Afzal V., Rubin E.M., Pennacchio L.A., Visel A. Tissue-Specific RNA Expression Marks Distant-Acting Developmental Enhancers. PLoS Genet. 2014;10:e1004610. doi: 10.1371/journal.pgen.1004610. - DOI - PMC - PubMed